231 related articles for article (PubMed ID: 36197839)
21. From micro- to nanostructured implantable device for local anesthetic delivery.
Zorzetto L; Brambilla P; Marcello E; Bloise N; De Gregori M; Cobianchi L; Peloso A; Allegri M; Visai L; Petrini P
Int J Nanomedicine; 2016; 11():2695-709. PubMed ID: 27354799
[TBL] [Abstract][Full Text] [Related]
22. Clinically established biodegradable long acting injectables: An industry perspective.
Nkanga CI; Fisch A; Rad-Malekshahi M; Romic MD; Kittel B; Ullrich T; Wang J; Krause RWM; Adler S; Lammers T; Hennink WE; Ramazani F
Adv Drug Deliv Rev; 2020 Dec; 167():19-46. PubMed ID: 33202261
[TBL] [Abstract][Full Text] [Related]
23. Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery.
Battiston K; Parrag I; Statham M; Louka D; Fischer H; Mackey G; Daley A; Gu F; Baldwin E; Yang B; Muirhead B; Hicks EA; Sheardown H; Kalachev L; Crean C; Edelman J; Santerre JP; Naimark W
Nat Commun; 2021 May; 12(1):2875. PubMed ID: 34001908
[TBL] [Abstract][Full Text] [Related]
24. Drug eluting implants in pharmaceutical development and clinical practice.
Johnson AR; Forster SP; White D; Terife G; Lowinger M; Teller RS; Barrett SE
Expert Opin Drug Deliv; 2021 May; 18(5):577-593. PubMed ID: 33275066
[No Abstract] [Full Text] [Related]
25. Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery.
Benhabbour SR; Kovarova M; Jones C; Copeland DJ; Shrivastava R; Swanson MD; Sykes C; Ho PT; Cottrell ML; Sridharan A; Fix SM; Thayer O; Long JM; Hazuda DJ; Dayton PA; Mumper RJ; Kashuba ADM; Victor Garcia J
Nat Commun; 2019 Sep; 10(1):4324. PubMed ID: 31541085
[TBL] [Abstract][Full Text] [Related]
26. Controlled Delivery of Chemopreventive Agents by Polymeric Implants.
Aqil F; Gupta RC
Methods Mol Biol; 2016; 1379():1-11. PubMed ID: 26608285
[TBL] [Abstract][Full Text] [Related]
27. Polyester-based microdisc systems for sustained release of neuroprotective phosphine-borane complexes.
Janus DA; Lieven CJ; Crowe ME; Levin LA
Pharm Dev Technol; 2018 Nov; 23(9):882-889. PubMed ID: 28524719
[TBL] [Abstract][Full Text] [Related]
28. Branched biodegradable polyesters for parenteral drug delivery systems.
Breitenbach A; Li YX; Kissel T
J Control Release; 2000 Feb; 64(1-3):167-78. PubMed ID: 10640655
[TBL] [Abstract][Full Text] [Related]
29. Titania nanotube arrays for local drug delivery: recent advances and perspectives.
Losic D; Aw MS; Santos A; Gulati K; Bariana M
Expert Opin Drug Deliv; 2015 Jan; 12(1):103-27. PubMed ID: 25376706
[TBL] [Abstract][Full Text] [Related]
30. Current advances in sustained-release systems for parenteral drug delivery.
Shi Y; Li LC
Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis.
Kluin OS; van der Mei HC; Busscher HJ; Neut D
Expert Opin Drug Deliv; 2013 Mar; 10(3):341-51. PubMed ID: 23289645
[TBL] [Abstract][Full Text] [Related]
32. Poly(ortho ester) biodegradable polymer systems.
Heller J; Himmelstein KJ
Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
[TBL] [Abstract][Full Text] [Related]
33. Controlled Release of Usnic Acid from Biodegradable Polyesters to Inhibit Biofilm Formation.
Dasgupta Q; Madras G; Chatterjee K
ACS Biomater Sci Eng; 2017 Mar; 3(3):291-303. PubMed ID: 33465928
[TBL] [Abstract][Full Text] [Related]
34. Three-Dimensional Printed PCL-Based Implantable Prototypes of Medical Devices for Controlled Drug Delivery.
Holländer J; Genina N; Jukarainen H; Khajeheian M; Rosling A; Mäkilä E; Sandler N
J Pharm Sci; 2016 Sep; 105(9):2665-2676. PubMed ID: 26906174
[TBL] [Abstract][Full Text] [Related]
35. Manufacturing techniques of biodegradable implants intended for intraocular application.
Fialho SL; da Silva Cunha A
Drug Deliv; 2005; 12(2):109-16. PubMed ID: 15824036
[TBL] [Abstract][Full Text] [Related]
36. Aliphatic polyesters and cellulose-based polymers for controlled release applications.
Chang RK; Price JC
J Biomater Appl; 1988 Jul; 3(1):80-101. PubMed ID: 3058931
[TBL] [Abstract][Full Text] [Related]
37. Selectively Biodegradable Polyesters: Nature-Inspired Construction Materials for Future Biomedical Applications.
Urbánek T; Jäger E; Jäger A; Hrubý M
Polymers (Basel); 2019 Jun; 11(6):. PubMed ID: 31248100
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
[TBL] [Abstract][Full Text] [Related]
39. The effect of HPMC and MC as pore formers on the rheology of the implant microenvironment and the drug release in vitro.
Aho J; Halme A; Boetker J; Water JJ; Bohr A; Sandler N; Rantanen J; Baldursdottir S
Carbohydr Polym; 2017 Dec; 177():433-442. PubMed ID: 28962789
[TBL] [Abstract][Full Text] [Related]
40. A Mechanistic Model for Acidic Drug Release Using Microspheres Made of PLGA 50:50.
Sevim K; Pan J
Mol Pharm; 2016 Aug; 13(8):2729-35. PubMed ID: 27398973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
